BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12052725)

  • 21. [Efavirenz and nevirapine plasma levels in HIV-infected patients with hemophilia].
    Martorell M; López RM; Ribera E; Ruiz I; Tural C; Puig L; Monterde J
    Enferm Infecc Microbiol Clin; 2005; 23(6):349-52. PubMed ID: 15970167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
    Choi SO; Rezk NL; Kashuba AD
    J Pharm Biomed Anal; 2007 Mar; 43(4):1562-7. PubMed ID: 17236737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography.
    Droste JA; Verweij-Van Wissen CP; Burger DM
    Ther Drug Monit; 2003 Jun; 25(3):393-9. PubMed ID: 12766571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen.
    Casado JL; Hertogs K; Ruiz L; Dronda F; Van Cauwenberge A; Arnó A; Garcia-Arata I; Bloor S; Bonjoch A; Blazquez J; Clotet B; Larder B
    AIDS; 2000 Jan; 14(2):F1-7. PubMed ID: 10708276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid determination of nevirapine in human plasma by gas chromatography.
    Langmann P; Schirmer D; Väth T; Desch S; Zilly M; Klinker H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 767(1):69-74. PubMed ID: 11863297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography.
    Verweij-van Wissen CP; Aarnoutse RE; Burger DM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):121-9. PubMed ID: 15664342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A validated new method for nevirapine quantitation in human plasma via high-performance liquid chromatography.
    Silverthorn CF; Parsons TL
    Biomed Chromatogr; 2006 Jan; 20(1):23-7. PubMed ID: 15920701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction.
    Dailly E; Thomas L; Kergueris MF; Jolliet P; Bourin M
    J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(2):129-35. PubMed ID: 11486821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of efavirenz, a selective non-nucleoside reverse transcriptase inhibitor, in human plasma using HPLC with post-column photochemical derivatization and fluorescence detection.
    Matthews CZ; Woolf EJ; Mazenko RS; Haddix-Wiener H; Chavez-Eng CM; Constanzer ML; Doss GA; Matuszewski BK
    J Pharm Biomed Anal; 2002 Jun; 28(5):925-34. PubMed ID: 12039635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid method for the quantitative determination of efavirenz in human plasma.
    Mogatle S; Kanfer I
    J Pharm Biomed Anal; 2009 Jul; 49(5):1308-12. PubMed ID: 19375262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous quantitative assay of six HIV protease inhibitors, one metabolite, and two non-nucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography.
    Tribut O; Arvieux C; Michelet C; Chapplain JM; Allain H; Bentué-Ferrer D
    Ther Drug Monit; 2002 Aug; 24(4):554-62. PubMed ID: 12142642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma.
    Villani P; Pregnolato M; Banfo S; Rettani M; Burroni D; Seminari E; Maserati R; Regazzi MB
    Ther Drug Monit; 1999 Jun; 21(3):346-50. PubMed ID: 10365651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simple and rapid liquid chromatography method for determination of efavirenz in plasma.
    Ramachandran G; Kumar AK; Swaminathan S; Venkatesan P; Kumaraswami V; Greenblatt DJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):131-5. PubMed ID: 16574512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NNRTIs: a neglected class.
    Cadman J
    GMHC Treat Issues; 1998 Sep; 12(9):6-10. PubMed ID: 11365807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous determination of the six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir) plus M8 nelfinavir metabolite and the nonnucleoside reverse transcription inhibitor efavirenz in human plasma by solid-phase extraction and column liquid chromatography.
    Poirier JM; Robidou P; Jaillon P
    Ther Drug Monit; 2002 Apr; 24(2):302-9. PubMed ID: 11897976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations.
    González de Requena D; Gallego O; Corral A; Jiménez-Nácher I; Soriano V
    AIDS; 2004 Oct; 18(15):2091-4. PubMed ID: 15577634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous determination of zidovudine and nevirapine in human plasma by RP-LC.
    Marchei E; Valvo L; Pacifici R; Pellegrini M; Tossini G; Zuccaro P
    J Pharm Biomed Anal; 2002 Aug; 29(6):1081-8. PubMed ID: 12110393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.
    De Clercq E
    Antiviral Res; 1998 Jun; 38(3):153-79. PubMed ID: 9754886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An LC-MS-MS method for the determination of nevirapine, a non-nucleoside reverse transcriptase inhibitor, in human plasma.
    Chi J; Jayewardene AL; Stone JA; Aweeka FT
    J Pharm Biomed Anal; 2003 Apr; 31(5):953-9. PubMed ID: 12684107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry.
    Nirogi R; Bhyrapuneni G; Kandikere V; Mudigonda K; Komarneni P; Aleti R; Mukkanti K
    Biomed Chromatogr; 2009 Apr; 23(4):371-81. PubMed ID: 18937306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.